Title
Herbal Medicine Registration Guidelines
Law
Doh Administrative Order No. 172, S. 2004
Decision Date
Sep 16, 2004
The Philippine Jurisprudence case provides guidelines and requirements for the registration and renewal of herbal medicines and pharmaceutical products, aiming to ensure their safety, efficacy, and quality, with prohibited acts and sanctions for non-compliance.
A

Scope and Coverage

  • Applies to all herbal medicines regulated by the Department of Health (DOH) through the Bureau of Food and Drugs (BFAD).
  • Excludes preparations that are fresh plant materials without processing beyond drying, packaging, and storage.
  • Non-herbal products fall under other applicable drug regulations.

Definitions

  • "Plant Material": Any fresh or dried part of a plant including juices and oils used for further processing or as is.
  • "Herbal Medicines": Finished medicinal products containing active plant materials with therapeutic claims for diagnosis or treatment in humans or animals.
  • Excludes drug preparations combining plant materials with chemically defined conventional drug substances.
  • Definition of common, scientific, and official names provided for clarity in labeling and documentation.

Policies and Guidelines

  • Only licensed establishments (manufacturers, traders, importers, distributors) can apply for herbal medicine registration.
  • Herbal medicines must be registered with BFAD before manufacture, importation, sale, distribution, advertisement, or transfer.

Registration Requirements

  • Submission of notarized application and Form No. 8.
  • Brand name clearance to prevent duplicate or confusing names, including rules for imported products.
  • Certificate of agreement among involved establishments.
  • Complete list of active and inactive ingredients with scientific and common names.
  • Certification of plant specimen authenticity by recognized taxonomists or Philippine National Museum.
  • Detailed physical description and quality standards of the finished product per Annex A.
  • Certificate of analysis and comprehensive manufacturing and quality control reports.
  • Stability studies under specified temperature and humidity conditions to support shelf-life claims.
  • Detailed labeling requirements including therapeutic claims, dosage, precautions, batch and registration numbers, and storage.
  • Samples of commercial presentation must be submitted for laboratory analysis.
  • Evidence of safety and efficacy data including toxicity studies, pharmacologic and clinical trials as applicable.
  • Special provisions for imported herbal medicines including authenticated Certificate of Pharmaceutical Product.
  • Renewal requirements outlined.

Registration Procedure

  • Licensed establishments file formal application with complete documentation and samples.
  • BFAD evaluates documents and conducts laboratory tests.
  • Final approval or denial based on evaluation results.
  • Payment of non-refundable registration and laboratory fees (initial and renewal, generic and branded rates specified).

Prohibited Acts and Sanctions

  • Prohibited acts and penalties under R.A. 3720 and E.O. 175 apply as appropriate.

Repealing Clause

  • Inconsistent orders, circulars, rules, or regulations are repealed or modified accordingly.

Effectivity

  • The regulations take effect fifteen days after publication in two newspapers of general circulation.

Annex A: Standards for Identity, Purity, and Quality

  • Authentication of plant materials through herbarium specimens.
  • Herbal medicines must be free from extraneous matter and meet pharmacopoeial standards or equivalent.
  • Required tests include organoleptic description, ash content, extractives, moisture content, heavy metals, pesticide residues, microbial limits, aflatoxin levels, chemical identification (TLC, HPLC, etc.), and bioassays.
  • Finished product quality tests include moisture, pH, microbial limits, and testing for synthetic substances.
  • Specific tests for various dosage forms such as tablets, capsules, liquids, ointments, and suppositories.
  • Galenical products must comply with national pharmacopeias.

Annex C: Packaging Requirements

  • Detailed information on materials used for plastic containers and special packaging.
  • Toxicity and technical tests must substantiate safety claims, especially for parenteral and ophthalmic preparations.
  • Compliance with official standards and thorough documentation required.

Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster, building context before diving into full texts. AI-powered analysis, always verify critical details.